MONDAY, AUGUST 21, 2017

New computer model estimates benefits of HIV care

Researchers from Johns Hopkins recently developed a new computer model that could save lives and dollars. Read More »

Study shows ivermectin treatment knocks out malaria

New studies demonstrate that using a Nobel prize-winning drug that knocks out parasitic worms may be effective against malaria. Read More »

MRF Meningococcus Genome Library crucial to UK fight against meningitis and septicaemiav

A recent study from the Meningitis Research Foundation categorized the many different kinds of meningococci that cause illnesses in Wales and England. Read More »

Multi-tasking flu vaccine may offer improved protection

Australian researchers recently discovered a method of improving the efficacy and cross-protective abilities of a vaccine for influenza A by adding one component. Read More »

SciVac Therapeutics to purchase VBI Vaccines

SciVac Therapeutics Inc. recently announced the company has agreed to purchase VBI Vaccines and merge the company to create a commercial-stage company. Read More »

Migrants arriving in E.U. increase risk of spreading disease

The European Centre for Disease Prevention and Control recently reported that the arrival of migrants in the European Union increases the risk of importing and spreading malaria as well as other vector-borne illnesses. Read More »

Janssen gains positive CHMP recommendation for EDURANT

Janssen-Cilag International NV recently received a positive opinion recommendation from the Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMEA), for the company’s EDURANT to battle HIV. Read More »

Women living in Ontario have higher HIV rates than other Canadians

A study to assess serious pregnancy and delivery complications shows that women in Ontario have higher rates of HIV than any other immigrants or women born in Canada. Read More »

Vaxart presents at Vaccine & ISV Congress in Seoul

At the Ninth Vaccine & International Society of Vaccines Congress in Seoul, Vaxart Inc. representatives presented positive results from two vaccine studies, an oral norovirus vaccine and an H1N1 influenza tablet. Read More »

Rotary donates $40.4 million to help eliminate polio

Rotary members recently made a $40.4 million donation to help eliminate polio worldwide by funding vaccination activities and surveillance systems. Read More »

Roll Back Malaria partners meet to discuss global strategy

Roll Back Malaria Partnership representatives discussed the best strategy for fighting malaria at the 64th Annual Meeting of the American Society of Tropical Medicine and Hygiene in Philadelphia last week. Read More »

Annual tuberculosis deaths drop by nearly half in 25 years

Health officials recently announced the global death rate for tuberculosis (TB) in 2015 is almost half compared to the figure from 1990. Read More »

Doctors Without Borders awaits further tests on malaria vaccine

Despite recommendations from the World Health Organization (WHO), Doctors Without Borders (known by its French acronym MSF) has not launched promotions for the use of RTS,S as a malaria vaccine. Read More »

Influenza virus identified in European Union nations

Researchers have been working hard to identify and characterize various virus and influenza strains to make better vaccines to protect people more effectively. Read More »

Meningococcal cases traced to three bacteria strains

Researchers from the University of Oxford recently identified three families of deadly bacteria that have caused 60 percent of the meningococcal disease cases in Wales and England for the last 20 years. Read More »

ACS Central Science analyzes immune system response to enhanced vaccines

Researchers from ACS Central Science recently reported they have found a new method of improving vaccines by directing the immune system response with specific molecules. Read More »

NIAID supports clinical research for HIV, other infectious diseases

The Division of AIDS (DIAIDS), a branch of the National Institute of Allergy and Infectious Diseases (NIAID), supports the clinical research for therapies designed to treat HIV infections and similar infectious diseases. Read More »

Discovery of single virus could enhance vaccines

Scientists say the discovery of a single virus that can generate a long-term immune response in specific areas of the body that are the first line of defense for fighting infections could be crucial to creating vaccines. Read More »

SIRION Biotech makes breakthrough in vaccine production

Scientists with SIRION Biotech recently reported that they have made significant progress with an innovative, breakthrough vaccine as novel production cell lines handle toxic antigens that are challenging to express. Read More »

South Africa's HIV/AIDS death rate declines

According to the official journal from the International AIDS Society, AIDS mortality rates have shown a decrease in South Africa from the disease’s height in 2007. Read More »